- Transparency or restricting gifts? Polish medical students’ opinions about regulating relationships with pharmaceutical sales representatives.Marcin Rodzinka, Emilia Kaczmarek & Marta Makowska - 2021 - Monash Bioethics Review 40 (Suppl 1):49-70.details
|
|
Medicines Information and the Regulation of the Promotion of Pharmaceuticals.Teresa Leonardo Alves, Joel Lexchin & Barbara Mintzes - 2019 - Science and Engineering Ethics 25 (4):1167-1192.details
|
|
A Social Epistemological Inquiry into Biases in Journal Peer Review.Saana Jukola - 2017 - Perspectives on Science 25 (1):124-148.details
|
|
(1 other version)Is it Really All about the Money? Reconsidering Non-Financial Interests in Medical Research.Richard S. Saver - 2012 - Journal of Law, Medicine and Ethics 40 (3):467-481.details
|
|
Addressing problems in profit-driven research: how can feminist conceptions of objectivity help?Kristen Intemann & Inmaculada de Melo-Martín - 2014 - European Journal for Philosophy of Science 4 (2):135-151.details
|
|
Pharmaceutical Industry discursives and the marketization of nursing work: a case example.Rusla Anne Springer - 2011 - Nursing Philosophy 12 (3):214-228.details
|
|
Bioethics in a clinic for women with psychosis.M. V. Seeman & B. Seeman - 2011 - Journal of Medical Ethics 37 (9):518-522.details
|
|
Ethics in the Discipline(s) of Bioethics.Stephen S. Hanson - 2011 - HEC Forum 23 (3):171-192.details
|
|
Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Trials of Medications. [REVIEW]Joel Lexchin - 2012 - Science and Engineering Ethics 18 (2):247-261.details
|
|
Minor Tweaks, Major Payoffs: The Problems and Promise of Situationism in Moral Philosophy.Hagop Sarkissian - 2010 - Philosophers' Imprint 10.details
|
|
Cheap Trinkets, Effective Marketing: Small Gifts from Drug Companies to Physicians.Allan S. Brett - 2003 - American Journal of Bioethics 3 (3):52-54.details
|
|
Access to Medication and Drug Company Sales Practices: Setting Priorities for Critique and Advocacy.Naomi Seiler - 2003 - American Journal of Bioethics 3 (3):61-61.details
|
|
Disclosing and managing non-financial conflicts of interest in scientific publications.David Resnik - 2023 - Research Ethics 19 (2):121-138.details
|
|
Shining Light on Conflicts of Interest.Craig Klugman - 2017 - American Journal of Bioethics 17 (6):1-3.details
|
|
Disclosing physician financial interests: Rebuilding trust or making unreasonable burdens on physicians?Daniel Sperling - 2017 - Medicine, Health Care and Philosophy 20 (2):179-186.details
|
|
On the conditions for objectivity : how to avoid bias in socially relevant research.Saana Jukola - unknowndetails
|
|
New Directions in Philosophy of Medicine.Jacob Stegenga, Ashley Kennedy, Serife Tekin, Saana Jukola & Robyn Bluhm - 2016 - In James A. Marcum (ed.), Bloomsbury Companion to Contemporary Philosophy of Medicine. New York: Bloomsbury. pp. 343-367.details
|
|
(1 other version)Is it Really All about the Money? Reconsidering Non-Financial Interests in Medical Research.Richard S. Saver - 2012 - Journal of Law, Medicine and Ethics 40 (3):467-481.details
|
|
Ethics: the physician–pharma dyad in India. [REVIEW]Meenakshi Handa, Anupama Vohra & Vinita Srivastava - 2014 - Asian Journal of Business Ethics 3 (1):1-10.details
|
|
The Pitfalls of Deducing Ethics From Behavioral Economics: Why the Association of American Medical Colleges Is Wrong About Pharmaceutical Detailing.Thomas S. Huddle - 2010 - American Journal of Bioethics 10 (1):1-8.details
|
|
All Rationalizations Large and Small.Bob Goodman - 2003 - American Journal of Bioethics 3 (3):57-58.details
|
|
Concussions, Professional Sports, and Conflicts of Interest: Why the National Football League’s Current Policies are Bad for Its Health. [REVIEW]Daniel S. Goldberg - 2008 - HEC Forum 20 (4):337-355.details
|
|
(2 other versions)Dialectical Interactions: Decoupling and Integrating Ethics in Ethics Initiatives.Spoma Jovanovic & Roy V. Wood - 2007 - Business Ethics Quarterly 17 (2):217-238.details
|
|
The Commercialization of Research and the Quest for the Objectivity of Science.S. Jukola - 2016 - Foundations of Science 21 (1):89-103.details
|
|
More Clarifications: On the Goals of Conflict of Interest Policies.Inmaculada de Melo-Martín - 2011 - American Journal of Bioethics 11 (1):35-37.details
|
|
How to evaluate conflict of interest policies.Daniel Strech & Hannes Knüppel - 2011 - American Journal of Bioethics 11 (1):37 - 39.details
|
|
A Response to Commentators on "All Gifts Large and Small".Dana Katz, Arthur L. Caplan & Jon F. Merz - 2003 - American Journal of Bioethics 3 (3):63-63.details
|
|
Voluntary Self-Regulatory Codes: What Should We Expect?Joel Lexchin - 2003 - American Journal of Bioethics 3 (3):49-50.details
|
|
The Invisible Influence of Industry Inducements.Rosamond Rhodes & James D. Capozzi - 2003 - American Journal of Bioethics 3 (3):65-67.details
|
|
Lunch with Lilly: Who Pays?Carson Strong - 2003 - American Journal of Bioethics 3 (3):62-63.details
|
|
Banning Pens and Pads Misses the Main Point.Sharon F. Terry & Wylie Burke - 2003 - American Journal of Bioethics 3 (3):63-65.details
|
|
Clinical ethics consulting and conflict of interest: Structurally intertwined.Christopher Meyers - 2007 - Hastings Center Report 37 (2):32-40.details
|
|
Conflict of interest: A tenacious ethical dilemma in public health policy, not only in clinical practice/research.Leslie London, Richard Matzopoulos, Joanne Corrigal, Jonathan Elliot Myers, Aadielah Maker & Charles Parry - 2012 - South African Journal of Bioethics and Law 5 (2).details
|
|
The Death of Common Sense.Howard Trachtman - 2003 - American Journal of Bioethics 3 (3):31-32.details
|
|
(2 other versions)Dialectical Interactions: Decoupling and Integrating Ethics in Ethics Initiatives.Spoma Jovanovic & Roy V. Wood - 2007 - Business Ethics Quarterly 17 (2):217-238.details
|
|
Managing the Risks of Corporate Political Donations: A Utilitarian Perspective.Shane Leong, James Hazelton & Cynthia Townley - 2013 - Journal of Business Ethics 118 (2):429-445.details
|
|
Pharmaceutical Industry Influences on Physician Prescribing: Gifts, Quasi-Gifts, and Patient-Directed Gifts.Jeffrey T. Berger - 2003 - American Journal of Bioethics 3 (3):56-57.details
|
|
Unconscious conflict of interest: a Jewish perspective.A. Gold & P. S. Appelbaum - 2011 - Journal of Medical Ethics 37 (7):402-405.details
|
|
Small Gifts, Conflicts of Interest, and the Zero-Tolerance Threshold in Medicine.Sheldon Krimsky - 2003 - American Journal of Bioethics 3 (3):50-52.details
|
|
Application of a sensemaking approach to ethics training in the physical sciences and engineering.Vykinta Kligyte, Richard T. Marcy, Ethan P. Waples, Sydney T. Sevier, Elaine S. Godfrey, Michael D. Mumford & Dean F. Hougen - 2008 - Science and Engineering Ethics 14 (2):251-278.details
|
|
Bribes for Doctors: A Gift for Bioethicists?Peter R. Mansfield - 2003 - American Journal of Bioethics 3 (3):47-48.details
|
|
The Ethics of Pharmaceutical Industry Gift-Giving: The Role of a Professional Association.Karine Morin & Leonard J. Morse - 2003 - American Journal of Bioethics 3 (3):54-55.details
|
|
Industry-to-physician marketing and the cost of prescription drugs.Winston Chiong - 2003 - American Journal of Bioethics 3 (3):28 – 29.details
|
|
Reciprocity’s Baggage.Jed Adam Gross - 2021 - American Journal of Bioethics 21 (4):94-97.details
|
|
Gifts, drug Samples, and other items given to medical specialists by pharmaceutical companies.Paul M. McNeill, Ian H. Kerridge, Catherine Arciuli, David A. Henry, Graham J. Macdonald, Richard O. Day & Suzanne R. Hill - 2006 - Journal of Bioethical Inquiry 3 (3):139-148.details
|
|
Pens and Other Pharmaceutical Industry Gifts.Howard Brody - 2003 - American Journal of Bioethics 3 (3):58-60.details
|
|
Response to Open Peer Commentaries on “The Pitfalls of Deducing Ethics from Economics: Why the Association of American Medical Colleges is Wrong About Pharmaceutical Detailing”.Thomas S. Huddle - 2010 - American Journal of Bioethics 10 (1):1-3.details
|
|
Public Perceptions of Health Care Professionals' Participation in Pharmaceutical Marketing.Nancy J. Crigger, Laura Courter, Kristen Hayes & K. Shepherd - 2009 - Nursing Ethics 16 (5):647-658.details
|
|